Hillsdale Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-53,300
| Closed | -$2.48M | – | 592 |
|
|
2022
Q4 | $2.48M | Hold |
53,300
| – | – | 0.21% | 150 |
|
|
2022
Q3 | $2.76M | Hold |
53,300
| – | – | 0.25% | 142 |
|
|
2022
Q2 | $2.52M | Hold |
53,300
| – | – | 0.2% | 153 |
|
|
2022
Q1 | $3.79M | Sell |
53,300
-650
| -1% | -$46.3K | 0.25% | 140 |
|
|
2021
Q4 | $4.04M | Buy |
+53,950
| New | +$4.04M | 0.27% | 127 |
|